Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
56.02 USD | +0.39% | +0.92% | +24.62% |
Apr. 12 | Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target is $48 | MT |
Apr. 08 | Sector Update: Health Care Stocks Decline Late Afternoon | MT |
- Stock Market
- Equities
- CTLT Stock
- News Catalent, Inc.